90
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Genotype Distribution and Prevalence of Human Papillomavirus Infection in Women in Northern Jiangsu Province of China

, &
Pages 7365-7372 | Published online: 22 Sep 2021

References

  • ChenW, ZhengR, BaadePD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132.26808342
  • BrayF, FerlayJ, SoerjomataramI, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
  • McLaughlin-DrubinME, MungerK. Viruses associated with human cancer. Biochim Biophys Acta Mol Basis Dis. 2008;1782(3):127–150.
  • ChanCK, AimagambetovaG, UkybassovaT, KongrtayK, AzizanA. Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination-review of current perspectives. J Oncol. 2019. doi:10.1155/2019/3257939
  • AsiafA, AhmadST, MohammadSO, ZargarMA. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection. Eur J Cancer Prev. 2014;23(3):206–224. doi:10.1097/CEJ.0b013e328364f27324129107
  • CreedS, WalshE, FoleyT. A qualitative study of parental views of HPV vaccination in Ireland. Eur J Gen Pract. 2021;27(1):1–9. doi:10.1080/13814788.2020.185167733496212
  • BoschFX, LorinczA, MunozN, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–265. doi:10.1136/jcp.55.4.24411919208
  • MunozN, BoschFX, de SanjoseS, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–527. doi:10.1056/NEJMoa02164112571259
  • de VilliersE-M. Cross-roads in the classification of papillomaviruses. Virology. 2013;445(1–2):2–10. doi:10.1016/j.virol.2013.04.02323683837
  • HoffmannM, QuabiusES. Relevance of human papillomaviruses in head and neck cancer-what remains in 2021 from a clinician’s point of view?Viruses. 2021;13(6):1173. doi:10.3390/v1306117334207440
  • YanyunL, XuC. Human papillomavirus-related cancers. Adv Exp Med Biol. 2017;1018:23–34.29052130
  • LuoG, SunX, LiM, et al. Cervical human papillomavirus among women in Guangdong, China 2008–2017: implication for screening and vaccination. J Med Virol. 2019;91(10):1856–1865. doi:10.1002/jmv.2552031206752
  • JiangL, TianX, PengD, et al. HPV prevalence and genotype distribution among women in Shandong Province, China: analysis of 94,489 HPV genotyping results from Shandong’s largest independent pathology laboratory. PLoS One. 2019;14(1):e0210311. doi:10.1371/journal.pone.021031130653566
  • WangJ, TangD, WangK, et al. HPV genotype prevalence and distribution during 2009–2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. BMC Womens Health. 2019;19:90. doi:10.1186/s12905-019-0785-331286939
  • YükselS, ŞimşekE, YetkinelS, et al. Clinicopathologic importance of atypical glandular cells in cervico-vaginal cytology. J Turk Ger Gynecol Assoc. 2020;21(2):102–106. doi:10.4274/jtgga.galenos.2019.2019.005931450881
  • BruniL, DiazM, CastellsagueX, et al. Cervical human papillomavirus prevalence in 5 continents: metaanalysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202:1789–1799. doi:10.1086/65732121067372
  • BekmukhambetovYZ, BalmagambetovaSK, JarkenovTA, NurtayevaSM, MukashevTZ, KoyshybaevAK. Distribution of high risk human papillomavirus types in Western Kazakhstan — retrospective analysis of PCR data. Asian Pac J Cancer Prev. 2016;17(5):2667–2672.27268648
  • ZhangWY, XueYZ, ChenM, et al. Prevalence of high-risk human papillomavirus infection in different cervical lesion among organized health-examination women in Shanghai, China. Chin Med J. 2008;121:1578–1582. doi:10.1097/00029330-200808020-0001518982872
  • DingX, LiuZ, SuJ, et al. Human papillomavirus type-specific prevalence in women referred for colposcopic examination in Beijing. J Med Virol. 2014;86(11):1937–1943. doi:10.1002/jmv.2404425132373
  • ZhangC, ChengW, LiuQ, et al. Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province. Virol J. 2019;16(1):67. doi:10.1186/s12985-019-1175-z31109361
  • BaoYP, LiN, WangH, QiaoYL. Study on the distribution of human papillomavirus types in cervix among Chinese women: a meta-analysis. Chin J Epidemiol. 2007;28(10):941–946. Article in Chinese.
  • BalmagambetovaS, GabuttiG, KoyshybaevA, et al. Cervical screening in Western Kazakhstan: liquid-based cytology ‘cell scan’ versus azur-eosin staining. J Med Screen. 2020;27:90–95. doi:10.1177/096914131988540931744375
  • de SanjoseS, QuintWG, AlemanyL, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a Retrospective Cross-Sectional Worldwide Study. Lancet Oncol. 2010;11:1048–1056. doi:10.1016/S1470-2045(10)70230-820952254
  • MeloniA, PiliaR, CampagnaM, et al. Prevalence and molecular epidemiology of human papillomavirus infection in Italian women with cervical cytological abnormalities. J Public Health Res. 2014;3:157. doi:10.4081/jphr.2014.15725170506
  • KantathavornN, MahidolC, SritanaN, et al. Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs. Infect Agent Cancer. 2015;10(1):1–9. article 7. doi:10.1186/s13027-015-0001-525589901
  • LiH, LiP, HuangL, et al. Prevalence characteristics of cervical human papillomavirus (HPV) infection in the Zhoupu District, Shanghai City, China. Virol J. 2020;17(1):84. doi:10.1186/s12985-020-01352-832586352
  • LiN, ZhangJ. Analysis of the distribution of human papillomavirus in the female genital tract of different ages. J Chin Pract Diagn Ther. 2012;26(9):909–911. Article in Chinese.
  • GuanP, Howell-JonesR, LiN, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349–2359. doi:10.1002/ijc.2748522323075